wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35057308-9B0D5F71-9AE0-4A69-8A3C-94B5964F6002
Q35057308-9B0D5F71-9AE0-4A69-8A3C-94B5964F6002
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35057308-9B0D5F71-9AE0-4A69-8A3C-94B5964F6002
Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis.
P2860
Q35057308-9B0D5F71-9AE0-4A69-8A3C-94B5964F6002
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35057308-9B0D5F71-9AE0-4A69-8A3C-94B5964F6002
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
85cd557a0e22a591271b6916847a39444edc1c0b
P2860
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.